A snapshot of the immunogenicity, efficacy and safety of a full course of BNT162b2 anti-SARS-CoV-2 vaccine in cancer patients treated with PD-1/PD-L1 inhibitors: a longitudinal cohort study
一项纵向队列研究：评估接受 PD-1/PD-L1 抑制剂治疗的癌症患者接种 BNT162b2 抗 SARS-CoV-2 疫苗全程的免疫原性、有效性和安全性
期刊:ESMO Open
影响因子:8.3
doi:10.1016/j.esmoop.2021.100272
Lasagna, A; Agustoni, F; Percivalle, E; Borgetto, S; Paulet, A; Comolli, G; Sarasini, A; Bergami, F; Sammartino, J C; Ferrari, A; Zavaglio, F; Arena, F; Lilleri, D; Secondino, S; Falzoni, M; Schiavo, R; Klersy, C; Lo Cascio, G; Cavanna, L; Baldanti, F; Pedrazzoli, P; Cassaniti, I
SARS-CoV-2
肿瘤
肿瘤免疫
PD-L1
PD-1
免疫/内分泌
